Charles M. Zelen, DPM Presents Level 1 Comparative Study on Nextremity Solutions’ 2-Piece Hammertoe Correction Device versus K-Wire Fixation During AOFAS 2015
Warsaw, IN July 28, 2015 — Nextremity Solutions’ Nextra® Hammertoe Correction System was most recently featured in an oral presentation given by Charles M. Zelen, DPM during the American Orthopaedic Foot and Ankle Society (AOFAS) congress held in Long Beach, CA.
Dr. Zelen presented a level 1 evidence study titled, “Prospective Randomized Multicenter Comparative Effectiveness Study Comparing; Two Component Modular Digital Implant Versus K-Wire Fixation For Surgical Correction of Hammertoes”, during morning sessions at AOFAS on July 16, 2015. This study highlighted scientific data that shows a 5.8X higher rate of bone fusion with the Nextra device compared to traditional K-Wires, as well as a 2.3X higher rate of Quality of Life over K-Wires.
Among the other key findings of this study were the following:
- 60% greater Reduction in Pain over K-Wires
- 3.3X better at decreasing patients’ level of Disability over K-wires
- 8.8X improvement in Activity compared to K-Wire
“This study was performed in order to show definitive proof with Level 1 evidence that Nextremity Solutions’ Nextra Hammertoe device was better for patients than the traditional means of hammertoe correction surgery using K-Wires.” said Dr. Zelen.
“It’s always good for a company to be able to put their claims to the test through studies like this one. Nextremity believes in good clinical research, and is willing to take the time and necessary investment to make this a reality. Nextra was designed by surgeons for surgeons and we can now clinically prove that when you listen to surgeon input, you develop a product that truly makes a difference in the lives of patients,” commented Nick A. Deeter, CEO and Chairman for Nextremity Solutions, Inc.
A copy of the comparative study can be found on www.nextremity.com/clinicalstudy, as well as a summary of the data.
About Charles M. Zelen, DPM
Charles M. Zelen, DPM is a graduate of California College of Podiatric Medicine, San Francisco. He did his surgical residency and internship at INOVA Fairfax Podiatric Surgical Residency Program and Northern Virginia Podiatric Residency Program affiliated with the Medical College of Virginia, Georgetown University Hospital, and INOVA Fairfax.
The American Orthopaedic Foot & Ankle Society (AOFAS), founded in 1969, is a medical specialty society comprised of more than 2,100 orthopaedic surgeons (MDs and DOs) from the US and abroad who specialize in the care of patients with injuries, diseases, and other conditions of the foot and ankle.
About Nextremity Solutions, Inc.
Nextremity Solutions, Inc. is a privately held medical device company offering innovative solutions and approaches to foot and ankle surgical intervention. The Company’s procedure-ready, sterile implant systems for the correction of foot and ankle pathologies include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.
For further information, visit www.nextremitysolutions.com or call Dave Temple, Director of Marketing & Corporate Communications at 574-635-3022.